Both in Biotechnology
Revolution Medicines vs Halozyme Therapeutics
Over the past year RVMD returned +241.0% and HALO returned +91.5%; their daily moves had a correlation of 0.17.
RVMD +241.0% HALO +91.5%Growth of $1, one year, split-adjusted
| Metric | RVMD | HALO |
|---|---|---|
| Price | $199.70 | $130.34 |
| Market cap | $42.80B | $14.79B |
| Today | +2.82% | +1.34% |
| 1 month | −0.1% | +18.8% |
| 6 months | +32.2% | +96.4% |
| Year to date | +150.7% | +93.7% |
| 1 year | +236.6% | +96.9% |
| Revenue growth (YoY) | — | +47.7% |
| Gross margin | — | 83.5% |
| Net margin | — | 47.8% |
| P/E (TTM) | — | 35.8× |
| Price / sales | — | 8.9× |
| Net cash | $3.45B | -$1.92B |
| Dividend yield | — | — |
| Volatility (60d) | 39.9% | 27.9% |
| Short % of float | 6.4% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).